The division offers a series of specialized senior fellowships that provide for fellows who demonstrate research promise and accomplishment with support beyond the period required for board certification. The division has major clinical research programs in breast cancer, gastrointestinal cancer, prostate cancer, developmental therapeutics and hematologic malignancies. The division participants in cooperative studies with Cancer and Leukemia Group B (CALGB) and the National Surgical Adjuvant Bowel and Breast Program (NSABP), among other groups.
Developmental Therapeutics Fellowship
Georgetown offers a one- to two-year Developmental Therapeutics Fellowship Program designed to train hematologists and oncologists for careers in academic clinical research, the pharmaceutical industry, or regulatory agencies.
The fellowship focuses on the early clinical trials of novel anti-cancer agents with an emphasis on clinical pharmacology and the regulatory requirements associated with new drug development. At the start of the program, fellows are given primary responsibility for one or two early clinical trials and are expected to complete, analyze, and publish the study during their fellowship. Training is coordinated with the Division of Clinical Pharmacology in the Department of Pharmacology and includes clinical trials methodology, research ethics, biostatistics, analytical drug assays, pharmacology, and pharmacokinetics. Course work at Georgetown or at the Food and Drug Administration (FDA) Staff College is encouraged. Fellows complete a three-month rotation at the FDA.
Cancer Control and Prevention Fellowship
The Georgetown Lombardi Cancer Prevention and Control Research Program Provides training in (1) molecular epidemiology research, where biological markers of risk and prognostic significance are identified and tested; (2) bio-behavioral research that aims to translate advances in molecular biology and epidemiology into state-of-the-art cancer prevention and control interventions; and (3) cancer geriatrics research that encompasses molecular epidemiology, health behavior, and health services research issues for the majority of most cancer patients who are elderly.
This program also provides opportunities for training through participation in multi-institutional research projects focusing on the prevention and control needs of low-income and medically underserved populations. For example, Georgetown Lombardi is collaborating with Johns Hopkins University to promote cancer screening and tobacco control among East Baltimore community organizations that already provide their low-income, black and white members an opportunity to buy food through a national food and community-service program. Georgetown Lombardi also is collaborating with the Washington Hospital Center to promote cancer screening and dietary modification to District of Columbia participants of the same program. Another national study based at Georgetown Lombardi is looking at the cost-effectiveness of breast-conserving surgery, with and without radiation therapy, versus modified radical mastectomy for early stage breast cancer among black and non white women age 65 and above.
Breast Cancer Fellowship
Georgetown Lombardi Cancer Center is home to a Specialized Program of Research Excellence (SPORE) in breast cancer. This SPORE grant recognizes and supports multidisciplinary translational research in breast cancer that has a high likelihood of influencing clinical care. The SPORE can support fellowship training research in one of the many Georgetown Lombardi laboratories that focus on molecular biology, cell biology, and drug development in breast cancer.